CNTNAP2 and encephalitis: The most commonly described variant was anti‐LGI1 encephalitis (13 studies, 139 patients), followed by anti‐GABABR (9 studies, 114 patients), and anti‐CASPR2 encephalitis (3 studies, 10 patients).